AR035420A1 - Un proceso para la preparacion de un compuesto imidazo-tetrazin-4-ona y un proceso para la preparacion de la temozolomida e intermediarios - Google Patents

Un proceso para la preparacion de un compuesto imidazo-tetrazin-4-ona y un proceso para la preparacion de la temozolomida e intermediarios

Info

Publication number
AR035420A1
AR035420A1 ARP020100141A ARP020100141A AR035420A1 AR 035420 A1 AR035420 A1 AR 035420A1 AR P020100141 A ARP020100141 A AR P020100141A AR P020100141 A ARP020100141 A AR P020100141A AR 035420 A1 AR035420 A1 AR 035420A1
Authority
AR
Argentina
Prior art keywords
preparation
compound
tetrazin
temozolomide
intermediaries
Prior art date
Application number
ARP020100141A
Other languages
English (en)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AR035420A1 publication Critical patent/AR035420A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Un proceso para la preparación de un compuesto imidazo-tetrazin-4-ona de la fórmula (1) en la cual R es un grupo alquilo C1-6, que comprende la reacción de un compuesto de la fórmula (2) en la cual R es como se lo definiera anteriormente, con un agente de oxidación/ciclación en presencia de un ioduro, en un medio inerte, bajo atmósfera inerte y a una temperatura y durante un lapso suficientes para producir un compuesto de la fórmula (1), donde dicho ioduro es soluble en dicho medio inerte, y un proceso para la preparación de la temozolomida e intermediarios. Antitumoral.
ARP020100141A 2001-01-18 2002-01-16 Un proceso para la preparacion de un compuesto imidazo-tetrazin-4-ona y un proceso para la preparacion de la temozolomida e intermediarios AR035420A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26246401P 2001-01-18 2001-01-18

Publications (1)

Publication Number Publication Date
AR035420A1 true AR035420A1 (es) 2004-05-26

Family

ID=22997625

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020100141A AR035420A1 (es) 2001-01-18 2002-01-16 Un proceso para la preparacion de un compuesto imidazo-tetrazin-4-ona y un proceso para la preparacion de la temozolomida e intermediarios

Country Status (9)

Country Link
US (1) US6844434B2 (es)
EP (1) EP1363911A1 (es)
JP (2) JP4441176B2 (es)
CN (1) CN1294132C (es)
AR (1) AR035420A1 (es)
CA (1) CA2434300A1 (es)
MX (1) MXPA03006402A (es)
SG (1) SG143062A1 (es)
WO (1) WO2002057268A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2275425A1 (en) * 2003-12-30 2011-01-19 Chemagis Ltd. Novel crystalline forms of temozolomide
CN100453543C (zh) * 2004-08-04 2009-01-21 天津天士力集团有限公司 一种替莫唑胺合成方法
US7612202B2 (en) 2005-02-17 2009-11-03 Chemagis, Ltd. Process for preparing temozolomide
CN1300143C (zh) * 2005-04-08 2007-02-14 江苏天士力帝益药业有限公司 替莫唑胺的精制方法
US20060257317A1 (en) * 2005-05-04 2006-11-16 Duke University Combination therapy in the treatment of cancer
US20060222792A1 (en) * 2006-04-21 2006-10-05 Chemagis Ltd. Temozolomide storage system
EP2374807B1 (en) 2006-09-29 2013-12-18 Cipla Limited An improved process for the isolation of temozolomide
CN101190917B (zh) * 2006-11-30 2011-07-13 天津天士力集团有限公司 3,4-二氢-3-甲基-4-氧代咪唑[5,1-d]并1,2,3,5-四嗪-8-甲酸苯磺酰基呋咱氮氧基酯类化合物,制备方法及其用途
EP2151442A3 (en) 2008-08-07 2011-04-06 Chemi SPA Process for preparing temozolomide
CN102405044A (zh) 2009-02-06 2012-04-04 南加利福尼亚大学 含有单萜的治疗组合物
CN102178676B (zh) * 2011-04-29 2012-07-25 山东大学 一种治疗脑胶质瘤的药物组合物
CN103626772B (zh) * 2012-08-24 2016-08-17 国药一心制药有限公司 一种替莫唑胺及中间体的合成方法
US10865209B2 (en) 2016-12-20 2020-12-15 Cristália Produtos Químicos Farmacêuticos Ltda Process for preparing temozolomide and an intermediary
US11597731B2 (en) 2021-07-17 2023-03-07 Shivalik Rasayan Limited Process for preparing highly pure temozolomide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260291A (en) 1981-08-24 1993-11-09 Cancer Research Campaign Technology Limited Tetrazine derivatives
GB2125402B (en) 1982-08-17 1985-11-13 May & Baker Ltd New tetrazine derivatives
ATE25521T1 (de) * 1982-12-20 1987-03-15 Merck & Co Inc 5-(amino oder substituierte amino)-imidazole.
GB8616125D0 (en) * 1986-07-02 1986-08-06 May & Baker Ltd Compositions of matter

Also Published As

Publication number Publication date
JP4441176B2 (ja) 2010-03-31
CA2434300A1 (en) 2002-07-25
MXPA03006402A (es) 2003-10-15
EP1363911A1 (en) 2003-11-26
US20020133006A1 (en) 2002-09-19
JP2009215316A (ja) 2009-09-24
CN1486319A (zh) 2004-03-31
WO2002057268A1 (en) 2002-07-25
SG143062A1 (en) 2008-06-27
CN1294132C (zh) 2007-01-10
JP2004517897A (ja) 2004-06-17
US6844434B2 (en) 2005-01-18

Similar Documents

Publication Publication Date Title
AR035420A1 (es) Un proceso para la preparacion de un compuesto imidazo-tetrazin-4-ona y un proceso para la preparacion de la temozolomida e intermediarios
EA200200481A1 (ru) Способ получения производных 4-трифторметилсульфинилпиразола
GR20010100097A (el) Μεθοδος παρασκευης της σιταλοπραμης
RU2008100767A (ru) Хиназолиновые соединения
NO992375D0 (no) FremgangsmÕte for fremstilling av benzylethere
CY1107589T1 (el) Υδροξυλιωση των βητα-δικαρβονυλιων με καταλυτες ζιρκονιου
US4916250B1 (es)
ATE435848T1 (de) Stabilisierte zusammensetzungen einer wässrigen lösung von reduziertem coenzym q
DE60233664D1 (de) Verfahren zur herstellung von pyridinverbindungen
EA200500122A1 (ru) Новые соединения, фармацевтические композиции, содержащие их, и способы их использования
DE60202203D1 (de) Neues verfahren zur herstellung von oxabispidinen
AU3745201A (en) Method for oxidizing a thioether group into a sulfoxide group
DE69513657D1 (de) Verfahren zur Herstellung von 1-substituierten 2-Cyanoimidazolen
HUP0300856A2 (hu) Eljárás szubsztituált fenil-acetonitrilek elżállítására
DK1254129T3 (da) Fremgangsmåde til fremstilling af 5-cyanophthalid
IL155181A0 (en) A process for the preparation of pantoprazole and intermediates therefor
BRPI0411664A (pt) composição oral antiplaca aquosa estável
FR2421205A1 (fr) Stabilisation de silicates aqueux au moyen de siliconates-silylalkylphosphonates de metaux alcalins
CO5011024A1 (es) Procedimiento para la obtencion de 3-hidroxipirazoles n-sustituidos
AR043505A1 (es) Preparacion de beta-cetoamidas e intermediarios de reaccion
RU2003114411A (ru) Способ получения замещенного анилинового соединения
ATE337304T1 (de) Neues verfahren zur herstellung einer chinolon- carbonsäure
ITMI20031813A1 (it) Procedimento per la preparazione di pantoprazolo e suoi sali.
PL349933A1 (en) Novel compounds beta-hydroxyalylamides, method of obtaining them and their application
SI0945430T1 (en) N-phenylacetoacetamides and process for their preparation

Legal Events

Date Code Title Description
FB Suspension of granting procedure